Positive Prelimary Results on Walkasins
RxFunction, announced positive interim results from its walk2Wellness study on Walkasins, a product designed to help peripheral neuropathy patients with balance issues. The results were presented by Lars Oddsson, PhD, Chief Technology Officer of RxFunction, at the American Congress of Rehabilitation Medicine in November 2019.
For more information, read here.
|